GE Aerospace Lands Thai Air Force Contract for Saab Gripen Fighter Jets Powered by F414-GE-39E Engines

Thursday, Aug 28, 2025 2:44 am ET1min read

GE Aerospace has signed a contract with the Royal Thai Air Force for four Saab Gripen E/F fighter aircraft equipped with F414-GE-39E engines. This marks Thailand's first adoption of the aircraft in the Asia-Pacific region and the third country globally after Sweden and Brazil. The F414 engine family has delivered over 1,600 engines with more than 5 million flight hours logged.

In a significant move for the defense industry, GE Aerospace has signed a contract with the Royal Thai Air Force for four Saab Gripen E/F fighter aircraft, each equipped with F414-GE-39E engines. This agreement marks Thailand's first adoption of the Gripen E/F in the Asia-Pacific region and the third country globally after Sweden and Brazil [1].

The F414-GE-39E engines, renowned for their power, reliability, and adaptability, will provide the next-generation combat capability needed for the Royal Thai Air Force's expanding fleet. GE Aerospace has delivered over 1,600 F414 engines, accumulating more than 5 million flight hours, demonstrating their proven performance in demanding environments [1].

Shawn Warren, vice president and general manager of Combat and Trainer Engines at GE Aerospace, expressed his honor in supporting Thailand's expansion of its Gripen fleet, highlighting the longstanding collaboration between GE Aerospace, Saab, and international air forces [1].

This deal underscores the growing demand for advanced fighter aircraft and the importance of strategic partnerships in the defense sector. The purchase aligns with Thailand's efforts to modernize its air force and enhance its regional security capabilities.

References:

[1] https://defence-industry.eu/ge-aerospace-f414-engines-to-power-royal-thai-air-forces-new-saab-gripen-e-f-fighter-aircraft/

GE Aerospace Lands Thai Air Force Contract for Saab Gripen Fighter Jets Powered by F414-GE-39E Engines

Comments



Add a public comment...
No comments

No comments yet